Delta Asset Management’s AbbVie ABBV Stock Holding History

Delta Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.68M	Sell	30,726 -364	-1%	-$80.7K	0.61%	30
2025 Q4	$7.1M	Sell	31,090 -1,609	-5%	-$367K	0.61%	31
2025 Q3	$7.57M	Sell	32,699 -41	-0.1%	-$8.35K	0.64%	31
2025 Q2	$6.08M	Sell	32,740 -284	-0.9%	-$52.8K	0.53%	32
2025 Q1	$6.92M	Sell	33,024 -2,811	-8%	-$546K	0.66%	32
2024 Q4	$6.37M	Sell	35,835 -1,388	-4%	-$255K	0.57%	31
2024 Q3	$7.35M	Sell	37,223 -1,202	-3%	-$224K	0.63%	31
2024 Q2	$6.59M	Sell	38,425 -478	-1%	-$79.2K	0.6%	32
2024 Q1	$7.08M	Sell	38,903 -810	-2%	-$140K	0.63%	33
2023 Q4	$6.15M	Sell	39,713 -954	-2%	-$139K	0.59%	33
2023 Q3	$6.06M	Buy	40,667 +190	+0.5%	+$27.9K	0.63%	32
2023 Q2	$5.45M	Sell	40,477 -151	-0.4%	-$22.1K	0.54%	35
2023 Q1	$6.47M	Buy	40,628 +3,227	+9%	+$493K	0.68%	33
2022 Q4	$6.04M	Buy	37,401 +83	+0.2%	+$12.7K	0.66%	34
2022 Q3	$5.01M	Buy	37,318 +323	+0.9%	+$46.4K	0.61%	35
2022 Q2	$5.67M	Sell	36,995 -132	-0.4%	-$20.2K	0.64%	34
2022 Q1	$6.02M	Buy	37,127 +2,360	+7%	+$343K	0.58%	34
2021 Q4	$4.71M	Buy	34,767 +3,925	+13%	+$464K	0.42%	37
2021 Q3	$3.33M	Buy	30,842 +3,071	+11%	+$351K	0.32%	39
2021 Q2	$3.13M	Buy	27,771 +11,119	+67%	+$1.25M	0.3%	41
2021 Q1	$1.8M	Buy	16,652 +6,025	+57%	+$644K	0.18%	46
2020 Q4	$1.14M	Buy	10,627 +2,715	+34%	+$261K	0.13%	55
2020 Q3	$693K	Hold	7,912	–	–	0.08%	69
2020 Q2	$777K	Sell	7,912 -230	-3%	-$20.3K	0.1%	66
2020 Q1	$620K	Hold	8,142	–	–	0.1%	67
2019 Q4	$721K	Hold	8,142	–	–	0.09%	71
2019 Q3	$617K	Buy	8,142 +1,700	+26%	+$117K	0.08%	75
2019 Q2	$468K	Hold	6,442	–	–	0.06%	82
2019 Q1	$519K	Buy	6,442 +2,578	+67%	+$211K	0.07%	74
2018 Q4	$356K	Buy	3,864 +50	+1%	+$4.4K	0.06%	89
2018 Q3	$361K	Buy	3,814 +500	+15%	+$47.4K	0.05%	99
2018 Q2	$307K	Hold	3,314	–	–	0.04%	100
2018 Q1	$314K	Hold	3,314	–	–	0.05%	97
2017 Q4	$320K	Hold	3,314	–	–	0.05%	94
2017 Q3	$294K	Hold	3,314	–	–	0.04%	94
2017 Q2	$241K	Hold	3,314	–	–	0.04%	99
2017 Q1	$216K	Sell	3,314 -211	-6%	-$13.3K	0.03%	103
2016 Q4	$221K	Hold	3,525	–	–	0.04%	100
2016 Q3	$222K	Hold	3,525	–	–	0.04%	99
2016 Q2	$218K	Hold	3,525	–	–	0.04%	100
2016 Q1	$201K	Hold	3,525	–	–	0.04%	102
2015 Q4	$209K	Sell	3,525 -25	-0.7%	-$1.44K	0.04%	104
2015 Q3	$194K	Sell	3,550 -65	-2%	-$4.23K	0.04%	102
2015 Q2	$243K	Hold	3,615	–	–	0.05%	96
2015 Q1	$211K	Hold	3,615	–	–	0.04%	101
2014 Q4	$236K	Hold	3,615	–	–	0.05%	94
2014 Q3	$209K	Hold	3,615	–	–	0.04%	98
2014 Q2	$204K	Hold	3,615	–	–	0.04%	97
2014 Q1	$186K	Hold	3,615	–	–	0.04%	101
2013 Q4	$191K	Buy	3,615 +65	+2%	+$3.19K	0.04%	102
2013 Q3	$159K	Sell	3,550 -250	-7%	-$11.1K	0.04%	109
2013 Q2	$157K	Buy	+3,800	New	+$166K	0.04%	112

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Delta Asset Management's ABBV Position: Q1 2026 in Review

Delta Asset Management reduced its AbbVie (ABBV) stake by 1.2% in Q1 2026, selling an estimated $80.7K and leaving 30,726 shares worth $6.68M. The position accounts for 0.61% of the portfolio, ranked #30.

Delta Asset Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.57M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Delta Asset Management held 30,726 shares of AbbVie worth $6.68M as of Q1 2026.
Delta Asset Management sold 364 AbbVie shares in Q1 2026, an estimated $80.7K.
AbbVie made up 0.61% of Delta Asset Management's portfolio in Q1 2026, its #30 holding.
Delta Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Delta Asset Management's AbbVie position peaked at $7.57M in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Delta Asset Management's 13F filing for Q1 2026, filed 11 May 2026.